Recorded September 19, 2023 | On-Demand Webinar
FDA and USPTO have initiated collaboration efforts following the issuance of Executive Order No. 14036, Promoting Competition in the American Economy, encouraging coordination among agencies with overlapping jurisdiction over industries. Earlier this year a joint USPTO-FDA Public Listening Session on Collaboration Initiatives was held to obtain public input on the PTO’s proposed initiatives to foster coordination between the agencies, enhance meaningful innovation in medical product development, and support a competitive marketplace to promote product access and affordability to the public. Panelists will discuss concerns and suggestions raised at this forum and opine on the changing landscape of innovation for industry and progress towards interagency coordination.